These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

467 related items for PubMed ID: 18468386

  • 1. Tablet formulation studies on an oxcarbazepine-beta cyclodextrin binary system.
    Patel NV, Chotai NP, Patel MP.
    Pharmazie; 2008 Apr; 63(4):275-81. PubMed ID: 18468386
    [Abstract] [Full Text] [Related]

  • 2. Tablet formulation studies on nimesulide and meloxicam-cyclodextrin binary systems.
    Nalluri BN, Chowdary KP, Murthy KV, Becket G, Crooks PA.
    AAPS PharmSciTech; 2007 May 11; 8(2):Article 36. PubMed ID: 17622114
    [Abstract] [Full Text] [Related]

  • 3. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov 11; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 4. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
    Ozdemir N, Ordu S.
    Drug Dev Ind Pharm; 1998 Jan 11; 24(1):19-25. PubMed ID: 15605593
    [Abstract] [Full Text] [Related]

  • 5. Development of fast-dissolving tablets of flurbiprofen-cyclodextrin complexes.
    Cirri M, Rangoni C, Maestrelli F, Corti G, Mura P.
    Drug Dev Ind Pharm; 2005 Aug 11; 31(7):697-707. PubMed ID: 16207617
    [Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo evaluation of novel immediate release carbamazepine tablets: complexation with hydroxypropyl-β-cyclodextrin in the presence of HPMC.
    Kou W, Cai C, Xu S, Wang H, Liu J, Yang D, Zhang T.
    Int J Pharm; 2011 May 16; 409(1-2):75-80. PubMed ID: 21371541
    [Abstract] [Full Text] [Related]

  • 7. Correlation and in vitro studies on radioactive and nonradioactive albendazole-beta-cyclodextrin complex tablets.
    Cetin EO, Ilem D, Gundogdu E, Asikoglu M, Kirilmaz L.
    Pharmazie; 2011 Sep 16; 66(9):672-6. PubMed ID: 22026122
    [Abstract] [Full Text] [Related]

  • 8. Tablet formulation containing meloxicam and beta-cyclodextrin: mechanical characterization and bioavailability evaluation.
    Ghorab MM, Abdel-Salam HM, El-Sayad MA, Mekhel MM.
    AAPS PharmSciTech; 2004 Jul 27; 5(4):e59. PubMed ID: 15760056
    [Abstract] [Full Text] [Related]

  • 9. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex.
    Wang L, Zeng F, Zong L.
    Pharm Dev Technol; 2013 Jul 27; 18(5):1101-10. PubMed ID: 22759202
    [Abstract] [Full Text] [Related]

  • 10. Ternary complexation of carvedilol, beta-cyclodextrin and citric acid for mouth-dissolving tablet formulation.
    Pokharkar V, Khanna A, Venkatpurwar V, Dhar S, Mandpe L.
    Acta Pharm; 2009 Jun 27; 59(2):121-32. PubMed ID: 19564138
    [Abstract] [Full Text] [Related]

  • 11. Studies on formulation development of mouth dissolving tablets of Carvedilol.
    Pokharkar V, Dhar S, Mandpe L.
    Hindustan Antibiot Bull; 2009 Jun 27; 49-50(1-4):21-8. PubMed ID: 19957540
    [Abstract] [Full Text] [Related]

  • 12. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
    Jug M, Maestrelli F, Bragagni M, Mura P.
    J Pharm Biomed Anal; 2010 May 01; 52(1):9-18. PubMed ID: 20004541
    [Abstract] [Full Text] [Related]

  • 13. Preparation and characterization of etoricoxib-beta-cyclodextrin complexes prepared by the kneading method.
    Patel HM, Suhagia BN, Shah SA, Rathod IS, Parmar VK.
    Acta Pharm; 2007 Sep 01; 57(3):351-9. PubMed ID: 17878114
    [Abstract] [Full Text] [Related]

  • 14. Solid-state characterization and dissolution properties of naproxen-arginine-hydroxypropyl-beta-cyclodextrin ternary system.
    Mura P, Bettinetti GP, Cirri M, Maestrelli F, Sorrenti M, Catenacci L.
    Eur J Pharm Biopharm; 2005 Jan 01; 59(1):99-106. PubMed ID: 15567306
    [Abstract] [Full Text] [Related]

  • 15. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
    Onyeji CO, Omoruyi SI, Oladimeji FA.
    Pharmazie; 2007 Nov 01; 62(11):858-63. PubMed ID: 18065103
    [Abstract] [Full Text] [Related]

  • 16. Development and evaluation of orally disintegrating tablets of cilostazol-β-cyclodextrin inclusion complexes.
    Desai C, Prabhakar B.
    Drug Dev Ind Pharm; 2015 Nov 01; 41(10):1589-607. PubMed ID: 25350555
    [Abstract] [Full Text] [Related]

  • 17. In vitro and in vivo evaluation of oral tablet formulations prepared with ketoconazole and hydroxypropyl-beta-cyclodextrin.
    Taneri F, Ozcan I, Guneri T.
    Drug Deliv; 2010 Apr 01; 17(3):152-7. PubMed ID: 20148713
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of dissolution and oral bioavailability of gliquidone with hydroxy propyl-beta-cyclodextrin.
    Sridevi S, Chauhan AS, Chalasani KB, Jain AK, Diwan PV.
    Pharmazie; 2003 Nov 01; 58(11):807-10. PubMed ID: 14664337
    [Abstract] [Full Text] [Related]

  • 19. Comparison of cefpodoxime proxetil release and antimicrobial activity from tablet formulations: complexation with hydroxypropyl-β-cyclodextrin in the presence of water soluble polymer.
    Gundogdu E, Koksal C, Karasulu E.
    Drug Dev Ind Pharm; 2012 Jun 01; 38(6):689-96. PubMed ID: 22010782
    [Abstract] [Full Text] [Related]

  • 20. Molecular simulation of hydroxypropyl-beta-cyclodextrin with hydrophobic selective Cox-II chemopreventive agent using host-guest phenomena.
    Sinha VR, Nanda A, Chadha R, Goel H.
    Acta Pol Pharm; 2011 Jun 01; 68(4):585-92. PubMed ID: 21796941
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.